Jamie L. Wagner - Concepedia

Author

Jamie L. Wagner

Also Known As

J Leitsmann, J Wagner, J. L. Wagner, J. Wagner, J.L. Wagner, Jamie L Wagner, Jamie L. Wagner, Jamie Lynn Wagner, Jamie Wagner

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center The University of Texas MD Anderson Cancer Center The University of Kansas Cancer Center University of Kansas NRG Oncology

About

Jamie L. Wagner is an author at University of Kansas Medical Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	1K
2	Health Sciences	5	5	102
3	Education	1	1	16
4	Engineering	1	1	19
5	Biomedical Engineering	1	1	19

Jamie L. Wagner

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing Priyanka Sharma, Jennifer R. Klemp, Bruce F. Kimler, Breast Cancer Research and Treatment Breast OncologyOncologyMedicineGynecologyPathology	2014	206
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Clinical Cancer Research	2016	137
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer Priyanka Sharma, Shane R. Stecklein, Rachel Yoder, JAMA Oncology	2023	135
Prospective Evaluation of the Nipple–Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer Jamie L. Wagner, Regina M. Fearmonti, Kelly K. Hunt, Annals of Surgical Oncology Surgical OncologyBreast OncologyMedicineProspective EvaluationRisk Reduction	2011	130
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz, Clinical Cancer Research	2018	125
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP) Priyanka Sharma, Bruce F. Kimler, Anne O’Dea, Clinical Cancer Research	2020	105
Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation Farrell Adkins, Ana M. González-Angulo, Xiudong Lei, Annals of Surgical Oncology Surgical OncologyBreast OncologyMedicineGynecologyPathology	2011	104
Biology, Treatment, and Outcome in Very Young and Older Women with DCIS Rosalinda Alvarado, Sara A. Lari, Robert E. Roses, Annals of Surgical Oncology Vulvar DiseasesVery YoungGeriatricsOlder WomenClinical Disease	2012	77
Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions Lyndsey J. Kilgore, Sabrina S. Korentager, Amanda N. Hangge, Annals of Surgical Oncology OncologyBioimpedance SensorsPatient Directed Self-interventionsBreast Cancer-related LymphedemaBreast Cancer	2018	77
Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population Min Yi, Henry M. Kuerer, Elizabeth A. Mittendorf, Journal of the American College of Surgeons	2012	72

Page 1